Delivery Order SPE2DB20D1050-SPE2DB24FH83K
Award Date
8/7/24
Potential Completion Date
8/8/24
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,346.35 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical distribution company. The order is for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has a completion date of February 20, 2024 and was awarded on February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The $1,077.04 firm fixed-price contract is for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine, to support federal healthcare programs. The award is not set-aside and has an ultimate completion date of July 25, 2024. Amerisourcebergen, through its Corporate Office division, has...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,646.80, is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has a firm fixed price pricing type and an ultimate completion date of March 17, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,496.37, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The order has an ultimate completion date of April 20, 2023 and was awarded on April 19, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The order has a ceiling value of $1,660.60 and an ultimate completion date of August 12, 2024. The contract is a firm fixed-price delivery order, and no set-aside designation was used. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company, to provide ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, with a total ceiling value of $1,354.96. The award has a period of performance through March 27, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025,...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The award, worth $1,346.30, has a final completion date of September 13, 2024. AmerisourceBergen, the prime contractor, is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $10,244.85, is for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is part of a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The $1,693.70 firm fixed price contract has a completion date of June 4, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a firm fixed price of $2,657.05 and a completion date of July 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...